Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia

[1]  J. Saurin,et al.  Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. , 2012, JAMA.

[2]  G. Inama,et al.  Natural History and Outcome of Hepatic Vascular Malformations in a Large Cohort of Patients with Hereditary Hemorrhagic Teleangiectasia , 2011, Digestive Diseases and Sciences.

[3]  J. Saurin,et al.  Long‐term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: A single‐center study , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  A. Guttmacher,et al.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia , 2009, Journal of Medical Genetics.

[5]  C. Shovlin,et al.  Hereditary haemorrhagic telangiectasia: a clinical and scientific review , 2009, European Journal of Human Genetics.

[6]  L. Adams,et al.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  G. Garcia‐Tsao.  Liver involvement in hereditary hemorrhagic telangiectasia (HHT). , 2007, Journal of hepatology.

[8]  Robert I. White,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[9]  W. Fischbach,et al.  Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab , 2006, Annals of Hematology.

[10]  J. Belghiti,et al.  Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry , 2006, Annals of surgery.

[11]  M. Manns,et al.  Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations , 2004, European Radiology.

[12]  D. Samuel,et al.  [Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience]. , 2002, Gastroenterologie clinique et biologique.

[13]  U. Settmacher,et al.  Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. , 2001, Transplantation.

[14]  D. Jain,et al.  Liver disease in patients with hereditary hemorrhagic telangiectasia. , 2000, The New England journal of medicine.

[15]  J. Korzenik,et al.  Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. , 2000, Journal of vascular and interventional radiology : JVIR.

[16]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[17]  H. Schlitt,et al.  Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. , 1998, Radiology.

[18]  Y. Becker,et al.  Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.